Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CBU | PLNT |
|---|---|---|
| Price | $60.13 | $42.07 |
| Change today | ▼ 0.92% | ▼ 0.80% |
| Market cap | $3.16B | $3.16B |
| Return, 3 months | -9.4% | -19.6% |
| Return, year to date | +7.1% | -61.2% |
| Return, 1 year | +5.1% | -57.1% |
| P/E (TTM) | 14.0 | 14.3 |
| P/B | 1.5 | -5.2 |
| P/E percentile vs own 5y | 2nd | 0th |
| Dividend yield | 3.13% | – |
| Revenue growth (YoY, latest qtr) | +12.2% | – |
| Net profit growth (YoY) | +19.5% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 27.4% | – |
| Return on equity | – | – |
| Analyst target vs. price | +15.9% | +62.7% |
| Analyst buy share | 0% | 79% |
| RSI (14) | 39 | 35 |
| 30-day volatility | 14.3% | 46.1% |
| Max drawdown, 1 year | -16.0% | -63.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
